Detalhe da pesquisa
1.
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
Eur Heart J
; 37(45): 3386-3395, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27578808
2.
Inferring demographic structure with moccasin size data from the Promontory Caves, Utah.
Am J Phys Anthropol
; 156(1): 76-89, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25297837
3.
[The evolving of cardiac interventions]. / Therapie der Herzerkrankungen im Wandel.
Ther Umsch
; 71(12): 707-12, 2014 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-25447084
4.
Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents.
Am Heart J
; 163(5): 876-886.e2, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22607867
5.
Sirolimus versus paclitaxel coronary stents in clinical practice.
Catheter Cardiovasc Interv
; 77(1): 5-12, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20506333
6.
Cardiovascular mortality and morbidity in patients undergoing percutaneous coronary intervention after out-of-hospital cardiac arrest: a systematic review and meta-analysis.
EuroIntervention
; 16(15): e1245-e1253, 2021 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624462
7.
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial.
J Cardiovasc Transl Res
; 14(1): 110-119, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096064
8.
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition.
EuroIntervention
; 17(11): e898-e909, 2021 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105513
9.
Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.
J Am Heart Assoc
; 10(12): e021965, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098740
10.
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.
Circulation
; 120(5): 391-9, 2009 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620501
11.
Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
Am Heart J
; 159(5): 891-898.e1, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20435201
12.
Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions.
Front Cardiovasc Med
; 7: 60, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32432125
13.
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines.
JACC Cardiovasc Interv
; 12(9): 820-830, 2019 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30981574
14.
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention.
JACC CardioOncol
; 1(2): 145-155, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396175
15.
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.
Circulation
; 115(18): 2426-34, 2007 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-17485593
16.
Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements.
Circulation
; 116(9): 975-83, 2007 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17679611
17.
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
N Engl J Med
; 353(7): 653-62, 2005 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-16105989
18.
Prognostic value of early exercise testing after coronary stent implantation.
Am J Cardiol
; 101(6): 807-11, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18328845
19.
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.
Circ Cardiovasc Interv
; 11(9): e006741, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30354590
20.
Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
Circ Cardiovasc Interv
; 11(5): e006132, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748219